250 related articles for article (PubMed ID: 32356146)
1. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV.
Matza LS; Paulus TM; Garris CP; Van de Velde N; Chounta V; Deger KA
Patient; 2020 Aug; 13(4):409-422. PubMed ID: 32356146
[TBL] [Abstract][Full Text] [Related]
2. Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV.
Matza LS; Howell TA; Chounta V; van de Velde N
Qual Life Res; 2023 Feb; 32(2):531-541. PubMed ID: 36512302
[TBL] [Abstract][Full Text] [Related]
3. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.
Fletcher L; Burrowes SAB; Khan GK; Sabin L; Johnson S; Kimmel SD; Ruiz-Mercado G; Pierre C; Drainoni ML
Harm Reduct J; 2023 Jan; 20(1):4. PubMed ID: 36627679
[TBL] [Abstract][Full Text] [Related]
4. Stakeholder efforts to mitigate antiretroviral therapy interruption among people living with HIV during the COVID-19 pandemic in China: a qualitative study.
Sun Y; Zhan Y; Li H; Yuan T; Gao Y; Liang B; Feng A; Li P; Zheng W; Fitzpatrick T; Wu D; Zhai X; Zou H
J Int AIDS Soc; 2021 Sep; 24(9):e25781. PubMed ID: 34473409
[TBL] [Abstract][Full Text] [Related]
5. A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs.
Fleming T; Collins AB; Bardwell G; Fowler A; Boyd J; Milloy MJ; Small W; McNeil R
PLoS One; 2021; 16(2):e0246999. PubMed ID: 33635886
[TBL] [Abstract][Full Text] [Related]
6. Drug use and antiretroviral therapy (ART) interactions: a qualitative study to explore the knowledge, beliefs, adherence, and quality of life of people living with HIV taking ART and illicit drugs.
Fuster-RuizdeApodaca MJ; Castro-Granell V; Laguía A; Jaén Á; Cenoz S; Galindo MJ
AIDS Res Ther; 2020 May; 17(1):24. PubMed ID: 32448214
[TBL] [Abstract][Full Text] [Related]
7. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy.
Dubé K; Eskaf S; Evans D; Sauceda J; Saberi P; Brown B; Averitt D; Martel K; Meija M; Campbell D; Barr L; Kanazawa J; Perry K; Patel H; Luter S; Poteat T; Auerbach JD; Wohl DA
AIDS Res Hum Retroviruses; 2020 Apr; 36(4):324-348. PubMed ID: 31608651
[TBL] [Abstract][Full Text] [Related]
8. Association between HIV stigma and antiretroviral therapy adherence among adults living with HIV: baseline findings from the HPTN 071 (PopART) trial in Zambia and South Africa.
Jones HS; Floyd S; Stangl A; Bond V; Hoddinott G; Pliakas T; Bwalya J; Mandla N; Moore A; Donnell D; Bock P; Fidler S; Hayes R; Ayles H; Hargreaves JR;
Trop Med Int Health; 2020 Oct; 25(10):1246-1260. PubMed ID: 32745296
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Freedom: Patient Experiences with the Transition from Daily Oral to Long-Acting Injectable Antiretroviral Therapy to Treat HIV in the Context of Phase 3 Trials.
Mantsios A; Murray M; Karver TS; Davis W; Margolis D; Kumar P; Swindells S; Bredeek UF; García Del Toro M; Garcia Gasalla M; Rubio García R; Antela A; Hudson K; Griffith S; Kerrigan D
AIDS Behav; 2020 Dec; 24(12):3473-3481. PubMed ID: 32410051
[TBL] [Abstract][Full Text] [Related]
10. Deterrents to HIV-patient initiation of antiretroviral therapy in urban Lusaka, Zambia: a qualitative study.
Musheke M; Bond V; Merten S
AIDS Patient Care STDS; 2013 Apr; 27(4):231-41. PubMed ID: 23530573
[TBL] [Abstract][Full Text] [Related]
11. [Adherence reinforcement for antiretroviral therapy: PLHIV's perceptions and experience in Burkina Faso].
Berthé-Sanou L; Sanou M; Berthé A; Ouédraogo R; Sawadogo AB; Drabo J; Moh R; Tubiana R; Slama L; Desclaux A
Sante Publique; 2019; 31(6):855-864. PubMed ID: 32550668
[TBL] [Abstract][Full Text] [Related]
12. "It is not that I forget, it's just that I don't want other people to know": barriers to and strategies for adherence to antiretroviral therapy among HIV patients in Northern Vietnam.
Van Tam V; Pharris A; Thorson A; Alfven T; Larsson M
AIDS Care; 2011 Feb; 23(2):139-45. PubMed ID: 21259125
[TBL] [Abstract][Full Text] [Related]
13. Experiences with long acting injectable ART: A qualitative study among PLHIV participating in a Phase II study of cabotegravir + rilpivirine (LATTE-2) in the United States and Spain.
Kerrigan D; Mantsios A; Gorgolas M; Montes ML; Pulido F; Brinson C; deVente J; Richmond GJ; Beckham SW; Hammond P; Margolis D; Murray M
PLoS One; 2018; 13(1):e0190487. PubMed ID: 29304154
[TBL] [Abstract][Full Text] [Related]
14. Adherence to antiretroviral therapy (ART) among people living with HIV (PLHIV): a cross-sectional survey to measure in Lao PDR.
Hansana V; Sanchaisuriya P; Durham J; Sychareun V; Chaleunvong K; Boonyaleepun S; Schelp FP
BMC Public Health; 2013 Jun; 13():617. PubMed ID: 23809431
[TBL] [Abstract][Full Text] [Related]
15. Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability.
Mcinziba A; Wademan D; Viljoen L; Myburgh H; Jennings L; Decloedt E; Orrell C; van Zyl G; van Schalkwyk M; Gandhi M; Hoddinott G
AIDS Care; 2023 Oct; 35(10):1628-1634. PubMed ID: 36781407
[TBL] [Abstract][Full Text] [Related]
16. Long-Acting Injectable Antiretroviral Treatment Acceptability and Preferences: A Qualitative Study Among US Providers, Adults Living with HIV, and Parents of Youth Living with HIV.
Simoni JM; Beima-Sofie K; Mohamed ZH; Christodoulou J; Tapia K; Graham SM; Ho R; Collier AC
AIDS Patient Care STDS; 2019 Mar; 33(3):104-111. PubMed ID: 30844308
[TBL] [Abstract][Full Text] [Related]
17. Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa.
Barry A; Ford N; El-Khatib Z
Trop Med Int Health; 2018 Mar; 23(3):270-278. PubMed ID: 29243867
[TBL] [Abstract][Full Text] [Related]
18. Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention: understanding potential users' ambivalences.
Carillon S; Gallardo L; Linard F; Chakvetadze C; Viard JP; Cros A; Molina JM; Slama L
AIDS Care; 2020 May; 32(sup2):155-161. PubMed ID: 32189506
[TBL] [Abstract][Full Text] [Related]
19. Assessment of satisfaction with antiretroviral drugs and the need for long-acting injectable medicines among people living with HIV in Japan and its associated factors: a prospective multicenter cross-sectional observational study.
Ishihara M; Hikasa S; Tsukiji M; Kunimoto Y; Nobori K; Kimura T; Onishi K; Yamamoto Y; Haruta K; Kashiwabara Y; Fujii K; Shimabukuro S; Watanabe D; Tsurumi H; Suzuki A
AIDS Res Ther; 2023 Aug; 20(1):62. PubMed ID: 37641099
[TBL] [Abstract][Full Text] [Related]
20. "A dream come true": Perspectives on long-acting injectable antiretroviral therapy among female sex workers living with HIV from the Dominican Republic and Tanzania.
Kerrigan D; Sanchez Karver T; Muraleetharan O; Savage V; Mbwambo J; Donastorg Y; Likindikoki S; Perez M; Gomez H; Mantsios A; Murray M; Beckham SW; Davis W; Galai N; Barrington C
PLoS One; 2020; 15(6):e0234666. PubMed ID: 32530939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
